Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Savage

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|October 24, 2025
Targeting the RXR Pathway for the Prevention of Triple Negative Breast CancerCassandra L Moyer, Jamal L Hill, Darian Coleman, et al.
Cancer Research|January 14, 2022
Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP InhibitorsKatrina M Lappin, Eliana M Barros, Satpal S Jhujh, et al.
Communications Biology|April 20, 2021
COMMD4 functions with the histone H2A-H2B dimer for the timely repair of DNA double-strand breaksAmila Suraweera, Neha S Gandhi, Sam Beard, et al.
Scientific Reports|May 4, 2013
Antiproton induced DNA damage: proton like in flight, carbon-ion like near restJ N Kavanagh, F J Currell, D J Timson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 5, 2024
Preventive Treatment with a CD73 Small Molecule Inhibitor Enhances Immune Surveillance in K-Ras Mutant Pancreatic Intraepithelial NeoplasiaLincoln N Strickland, Wendao Liu, Usama Hussein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2014
Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancerMatthew D Burstein, Anna Tsimelzon, Graham M Poage, et al.
The Journal of Pathology|June 28, 2011
PARP inhibition induces BAX/BAK-independent synthetic lethality of BRCA1-deficient non-small cell lung cancerIan Paul, Kienan I Savage, Jaine K Blayney, et al.
Molecular Cancer Therapeutics|September 30, 2025
Repurposing of the Macrolide Antibiotic Clarithromycin for the Prevention of Lung CancerShanshan Deng, Tabish Hussain, Thais F Bartelli, et al.
Journal of the National Cancer Institute|October 7, 2016
Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast CancerEileen E Parkes, Steven M Walker, Laura E Taggart, et al.
Molecular Cell|April 22, 2014
Identification of a BRCA1-mRNA splicing complex required for efficient DNA repair and maintenance of genomic stabilityKienan I Savage, Julia J Gorski, Eliana M Barros, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Cancer Prevention Research (Philadelphia, Pa.)|October 24, 2025
Targeting the RXR Pathway for the Prevention of Triple Negative Breast CancerCassandra L Moyer, Jamal L Hill, Darian Coleman, et al.
Cancer Research|January 14, 2022
Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP InhibitorsKatrina M Lappin, Eliana M Barros, Satpal S Jhujh, et al.
Communications Biology|April 20, 2021
COMMD4 functions with the histone H2A-H2B dimer for the timely repair of DNA double-strand breaksAmila Suraweera, Neha S Gandhi, Sam Beard, et al.
Scientific Reports|May 4, 2013
Antiproton induced DNA damage: proton like in flight, carbon-ion like near restJ N Kavanagh, F J Currell, D J Timson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 5, 2024
Preventive Treatment with a CD73 Small Molecule Inhibitor Enhances Immune Surveillance in K-Ras Mutant Pancreatic Intraepithelial NeoplasiaLincoln N Strickland, Wendao Liu, Usama Hussein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2014
Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancerMatthew D Burstein, Anna Tsimelzon, Graham M Poage, et al.
The Journal of Pathology|June 28, 2011
PARP inhibition induces BAX/BAK-independent synthetic lethality of BRCA1-deficient non-small cell lung cancerIan Paul, Kienan I Savage, Jaine K Blayney, et al.
Molecular Cancer Therapeutics|September 30, 2025
Repurposing of the Macrolide Antibiotic Clarithromycin for the Prevention of Lung CancerShanshan Deng, Tabish Hussain, Thais F Bartelli, et al.
Journal of the National Cancer Institute|October 7, 2016
Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast CancerEileen E Parkes, Steven M Walker, Laura E Taggart, et al.
Molecular Cell|April 22, 2014
Identification of a BRCA1-mRNA splicing complex required for efficient DNA repair and maintenance of genomic stabilityKienan I Savage, Julia J Gorski, Eliana M Barros, et al.
Pageof 7